BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8209275)

  • 41. Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy).
    Kaasa S; Mastekaasa A; Thorud E
    Acta Oncol; 1988; 27(4):343-9. PubMed ID: 2849461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiotherapy plus lonidamine in non-small cell lung cancer.
    Cionini L
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):49-52. PubMed ID: 1851578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer.
    Trovò MG; Zanelli GD; Minatel E; Franchin G; Gobitti C
    Int J Radiat Oncol Biol Phys; 1992; 24(3):573-4. PubMed ID: 1328119
    [No Abstract]   [Full Text] [Related]  

  • 44. A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer.
    Bull CA; Langlands AO; Tiver KW
    Radiother Oncol; 1988 Aug; 12(4):339, 341-2. PubMed ID: 2847253
    [No Abstract]   [Full Text] [Related]  

  • 45. Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire.
    Kaasa S; Mastekaasa A; Naess S
    Acta Oncol; 1988; 27(4):335-42. PubMed ID: 2849460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized trial of two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status.
    Lander FA; Ritchie DM
    Clin Oncol (R Coll Radiol); 1996; 8(6):408. PubMed ID: 8973864
    [No Abstract]   [Full Text] [Related]  

  • 47. Measurability of non-small-cell lung cancer on chest radiographs.
    Herschorn S; Hanley J; Wolkove N; Cohen C; Frank H; Palayew M; Kreisman H
    J Clin Oncol; 1986 Aug; 4(8):1184-90. PubMed ID: 3734847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
    Newman CE; Cox R; Ford CH; Johnson JR; Jones DR; Wheaton M
    Br J Cancer; 1985 May; 51(5):731-2. PubMed ID: 3888243
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical trials (phase 1-2) of hypoxic radiotherapy].
    Neumeister K
    Med Radiol (Mosk); 1984 Jun; 29(6):78-9. PubMed ID: 6376997
    [No Abstract]   [Full Text] [Related]  

  • 50. Translational research in radiotherapy trials.
    West C; McKeown S
    Br J Radiol; 2006 Sep; 79(945):716-8. PubMed ID: 16940372
    [No Abstract]   [Full Text] [Related]  

  • 51. A retrospective study investigating the impact of radical radiotherapy on the nutritional status of patients with lung cancer.
    White R; Palmgren E
    Clin Nutr ESPEN; 2015 Oct; 10(5):e210. PubMed ID: 28531546
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical trials in the next decade.
    HELLER JR
    Am J Roentgenol Radium Ther Nucl Med; 1963 Jan; 89():6-9. PubMed ID: 13953589
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical Trials and Molecular Radiotherapy.
    Buscombe JR
    World J Nucl Med; 2015; 14(2):73-4. PubMed ID: 26097415
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.
    BMJ; 1995 Oct; 311(7010):899-909. PubMed ID: 7580546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
    Wolf M; Hans K; Becker H; Hässler R; von Bültzingslöwen F; Goerg R; Klaasen HA; Dannhäuser J; Holle R; Pfab R
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
    Kubota K
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
    Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P
    Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer.
    Cullen MH
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):34-41. PubMed ID: 8209275
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.